These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19766262)

  • 1. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].
    Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B
    Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
    Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
    J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
    J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
    Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
    J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Fujieda K; Mukai T
    Nihon Rinsho; 2004 Feb; 62(2):361-7. PubMed ID: 14968546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for 21-hydroxylase deficiency: results of CYP21 molecular genetic analysis.
    Witchel SF; Nayak S; Suda-Hartman M; Lee PA
    J Pediatr; 1997 Aug; 131(2):328-31. PubMed ID: 9290628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital adrenal hyperplasia: diagnostic advances.
    Torresani T; Biason-Lauber A
    J Inherit Metab Dis; 2007 Aug; 30(4):563-75. PubMed ID: 17694353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene.
    Lekarev O; Tafuri K; Lane AH; Zhu G; Nakamoto JM; Buller-Burckle AM; Wilson TA; New MI
    J Perinatol; 2013 Jan; 33(1):76-8. PubMed ID: 23269230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: molecular analysis of congenital adrenal hyperplasia in a newborn screening program.
    Killeen AA
    Mol Diagn; 2001 Sep; 6(3):189-91. PubMed ID: 11571712
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital adrenal hyperplasia: phenotype and genotype.
    Hughes I
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1329-40. PubMed ID: 12510987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adrenal hyperplasia as a result of 21-hydroxylase deficiency: prenatal diagnosis and treatment. Neonatal diagnosis].
    Lambotte C
    Rev Med Liege; 1986 Jan; 41(2):37-44. PubMed ID: 3006204
    [No Abstract]   [Full Text] [Related]  

  • 17. [Partial 3ß-hydroxysteroid dehydrogenase type 2 deficiency: Diagnosis of a novel mutation after positive newborn screening for 21-hydroxylase deficiency].
    Bahíllo-Curieses MP; Loidi Fernández de Trocóniz L; del Cañizo López A; Martínez-Sopena MJ
    Med Clin (Barc); 2016 Jan; 146(2):92-3. PubMed ID: 26021573
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital adrenal hyperplasia.
    Wedell A
    Clin Biochem; 2011 May; 44(7):505-506. PubMed ID: 22036349
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
    Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
    Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.